Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Goh, Robin Y H ^a   Bova, Ron ^a,b   Fogarty, Gerald B ^a,c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ST VINCENT'S CLINIC   (Australia)

^d 3 9 Gillies St   (Australia)

Author keywords

Audit; Head and neck; Immune suppression; Metastasis; Neck lymph nodes; Parotidectomy; Radiotherapy; Skin cancer

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; IMMUNE DEFICIENCY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; NECK METASTASIS; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; PROPORTIONAL HAZARDS MODEL; SKIN CARCINOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAROTID NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84862634895     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-117     Document Type: Article

References (16)

1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146:283-287. 10.1001/archdermatol.2010.19, 20231499.
2. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006, 184:6-10.
3. Australian cancer incidence and mortality workbooks (ACIM) 2010, AIHW, Canberra, Retrieved from [www.aihw.gov.au/cancer/data/acim_books/index.cfm] on 13 October 2011.
4. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 26:1-26. 10.1016/0190-9622(92)70001-V, 1732313.
5. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002, 24:417-422. 10.1002/hed.10063, 12001070.
6. Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA, . Committee for Neck Dissection Classification, American Head and Neck Society Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008, 134:536-538. 10.1001/archotol.134.5.536, 18490577, Committee for Neck Dissection Classification, American Head and Neck Society.
7. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis - An independent prognostic factor for head and neck cutaneous squamous cell carcinoma. Journal of Plastic, Reconstructive & Aesthetic Surgery 2006, 59:1288-129. 10.1016/j.bjps.2006.03.043, 22893785.
8. Chua MS, Veness MJ, Morgan G, Shakespeare T, Hehir A, Gebski V, Cakir B, Tiver KW. Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy. Australas Radiol 2002, 46:174-179. 10.1046/j.1440-1673.2001.01030.x, 12060157.
9. Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Archives of otolaryngology- head & neck surgery 2003, 129:750-753. 10.1001/archotol.129.7.750, 22710503.
10. Dona E, Veness MJ, Cakir B, Morgan GJ. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg 2003, 73:692-696. 10.1046/j.1445-2197.2003.02737.x, 12956783.
11. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003, 113:1827-1833.
12. Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005, 115:870-875. 10.1097/01.MLG.0000158349.64337.ED, 15867656.
13. Martinez JC, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, Weaver AL. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003, 139:301-306.
14. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, Morgan GW. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999, 85:1758-1764. 10.1002/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F, 10223570.
15. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001, 73:744-748.
16. Bova R, Saylor A, Coman WB. Parotidectomy: review of treatment and outcomes. ANZ J Surg 2004, 74:563-568. 10.1111/j.1445-2197.2004.02988.x, 15230791.